Page last updated: 2024-10-22

am 251 and Mononeuropathies

am 251 has been researched along with Mononeuropathies in 1 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Mononeuropathies: Disease or trauma involving a single peripheral nerve in isolation, or out of proportion to evidence of diffuse peripheral nerve dysfunction. Mononeuropathy multiplex refers to a condition characterized by multiple isolated nerve injuries. Mononeuropathies may result from a wide variety of causes, including ISCHEMIA; traumatic injury; compression; CONNECTIVE TISSUE DISEASES; CUMULATIVE TRAUMA DISORDERS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Novellis, V1
Vita, D1
Gatta, L1
Luongo, L1
Bellini, G1
De Chiaro, M1
Marabese, I1
Siniscalco, D1
Boccella, S1
Piscitelli, F1
Di Marzo, V1
Palazzo, E1
Rossi, F1
Maione, S1

Other Studies

1 other study available for am 251 and Mononeuropathies

ArticleYear
The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats.
    Molecular pain, 2011, Jan-17, Volume: 7

    Topics: Amidohydrolases; Amygdala; Animals; Arachidonic Acids; Benzamides; Carbamates; Electric Stimulation;

2011